| Name | Title | Contact Details |
|---|---|---|
Larry McNutt |
Chief Technology Officer | Profile |
When we learned that roughly 80% of medical records are unstructured, we felt compelled to step in. Without structured data, those along the continuum of care are unable to extract clinical context and automate functions that can improve patient care, enhance clinical documentation, streamline medical coding accuracy, and improve reimbursements - all of which are integral to a healthy revenue cycle. BUDDI.AI is the leading provider of clinical and revenue cycle automation solutions for healthcare. Our platform leverages artificial intelligence and deep learning to drive better clinical and financial outcomes for providers, payers, patients, and everyone in-between.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
PLD Applications Inc is a San Jose, CA-based company in the Computers and Electronics sector.
JPS Computer Services is a Hawthorne, NJ-based company in the Computers and Electronics sector.
EOS is a Springfield, IL-based company in the Computers and Electronics sector.